Overall, our findings demonstrate that simultaneous Arid1a loss and β-catenin activation in single hepatocytes, occurring in a physiological but non-cancerous context, are responsible for a major hematological disorder that is linked to de novo expression and subsequent secretion of hepatic Epo. Here, ARID1A is linked to hematologic disorder.